Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mosquito-Borne Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02553369
What this trial is testing

Seroprevalence of Chikungunya at the End of the First Chikungunya Outbreak in the French Antilles Within a Sample of Patients Treated for a HIV Infection

Who this might be right for
HIV InfectionsChikungunya Virus Infection
University Hospital Center of Martinique 388
Testing effectiveness (Phase 2)Study completedNCT03992872
What this trial is testing

Phase 2 Open-label Study of Alum-adjuvanted Chikungunya Virus-like Particle Vaccine (PXVX0317)

Who this might be right for
Chikungunya
Bavarian Nordic 60
Large-scale testing (Phase 3)Study completedNCT03640403
What this trial is testing

Effectiveness and Safety of Intermittent Preventive Treatment for Malaria Using Either Dihydroartemisinin-piperaquine or Artesunate-amodiaquine in Reducing Malaria Related Morbidities and Improving Cognitive Ability in School-aged Children in Tanzania

Who this might be right for
Malaria,FalciparumAnemia
National Institute for Medical Research, Tanzania 1,555
Large-scale testing (Phase 3)Ended earlyNCT04368910
What this trial is testing

Safety and Efficacy of Pyronaridine Artesunate Vs Chloroquine in Children and Adult Patients With Acute Vivax Malaria

Who this might be right for
Malaria
Medicines for Malaria Venture 30
Large-scale testing (Phase 3)Study completedNCT01935882
What this trial is testing

Low Dose Primaquine for Clearance of Gametocytes

Who this might be right for
MalariaAsymptomatic MalariaPlasmodium Falciparum
London School of Hygiene and Tropical Medicine 360
Not applicableStudy completedNCT06268691
What this trial is testing

Sustainable Reduction of Dengue in Colombia: Vector Breeding Site Intervention With an Insecticidal Coating

Who this might be right for
DengueVector Borne DiseasesArbovirus Infections+2 more
Rocio Cardenas Sanchez 35,000
Testing effectiveness (Phase 2)Study completedNCT02741128
What this trial is testing

Safety and Immunogenicity of a Tetravalent Dengue Vaccine in HIV-Positive Adults

Who this might be right for
Dengue FeverDengue Hemorrhagic FeverHuman Immunodeficiency Virus
Sanofi Pasteur, a Sanofi Company 133
Testing effectiveness (Phase 2)Study completedNCT00890760
What this trial is testing

Assess the Effectiveness of a New Malaria Vaccine Candidate by Infecting Vaccinated Volunteers With Malaria Parasites

Who this might be right for
Malaria
University of Oxford 55
Early research (Phase 1)Study completedNCT03510481
What this trial is testing

Safety, Immunogenicity, and Protective Efficacy of Two Regimens of Radiation Attenuated Plasmodium Falciparum NF54 Sporozoites (PfSPZ Vaccine) During Natural Transmission Season in Healthy African Adults in Mali

Who this might be right for
Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 478
Large-scale testing (Phase 3)Study completedNCT00595465
What this trial is testing

Comparison of Three Commercial Batches of the Japanese Encephalitis Vaccine IC51

Who this might be right for
Japanese Encephalitis
Valneva Austria GmbH 389
Post-approval studies (Phase 4)Study completedNCT05980156
What this trial is testing

Comparing Chemoprevention Drugs for School-based Malaria Control

Who this might be right for
Malaria,FalciparumAnemia in Children
University of Maryland, Baltimore 646
Not applicableEnded earlyNCT03161444
What this trial is testing

Estimated Cumulative Incidence of Zika Infection at the End of the First Epidemic in the French West Indies in a Sample of Patients Followed for HIV Infection.

Who this might be right for
HIV InfectionsZika Virus Infection
University Hospital Center of Martinique 354
Not applicableStudy completedNCT01954264
What this trial is testing

Epidemiology Study of Malaria Transmission Intensity in Sub-Saharan Africa

Who this might be right for
Malaria
GlaxoSmithKline 2,421
Post-approval studies (Phase 4)Study completedNCT00549003
What this trial is testing

Efficacy and Cost Effectiveness of Malaria Diagnosis Procedures and the Rational Use of ACT in Zanzibar

Who this might be right for
Malaria
Karolinska University Hospital 9,346
Testing effectiveness (Phase 2)UnknownNCT00849602
What this trial is testing

The Effect of Chloroquine in the Treatment of Patients With Dengue

Who this might be right for
Dengue
University of Sao Paulo 132
Post-approval studies (Phase 4)Looking for participantsNCT07038837
What this trial is testing

Comparison of Two Strategies for Administering the R21-Matrix M Vaccine in a Context of Seasonal Malaria Transmission in Chad

Who this might be right for
Malaria InfectionMalaria Vaccines
Epicentre 70,000
Early research (Phase 1)Study completedNCT02780154
What this trial is testing

PfSPZ Challenge in Non-immune Adults in Baltimore, USA

Who this might be right for
Plasmodium Falciparum Infection
National Institute of Allergy and Infectious Diseases (NIAID) 30
Large-scale testing (Phase 3)Study completedNCT01001988
What this trial is testing

Long-term Follow-up of Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Toddlers

Who this might be right for
EncephalitisJapanese Encephalitis
Sanofi Pasteur, a Sanofi Company 596
Post-approval studies (Phase 4)Study completedNCT02940756
What this trial is testing

Efficacy and Safety of Artemisinin-based Combination Treatments in the Democratic Republic of the Congo

Who this might be right for
Malaria
Ministry of Public Health, Democratic Republic of the Congo 1,615
Early research (Phase 1)Looking for participantsNCT06862453
What this trial is testing

Safety, Tolerability and Efficacy of PfSPZ-LARC2 Vaccine Against CHMI in Malaria-Naïve Adults

Who this might be right for
Malaria Falciparum
Sanaria Inc. 58
Next Page